<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2078">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 18, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04745923</url>
  </required_header>
  <id_info>
    <org_study_id>GO 21/127</org_study_id>
    <nct_id>NCT04745923</nct_id>
  </id_info>
  <brief_title>Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic</brief_title>
  <official_title>Fear of COVID-19 and Physical Activity Level in Patients With Chronic Kidney Disease During COVID-19 Pandemic</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hacettepe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hacettepe University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the literature, there are no studies evaluating fear of COVID-19, anxiety, depression,&#xD;
      physical activity, fear of movement and quality of life in patients with chronic kidney&#xD;
      disease during COVID-19 pandemic. The investigators will evaluate these parameters in&#xD;
      patients with chronic kidney disease and compare the findings of healthy individuals during&#xD;
      COVID-19 pandemic&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 20, 2021</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Fear of COVID-19</measure>
    <time_frame>5 minutes</time_frame>
    <description>COVID-19 phobia will be evaluated using Fear of COVID-19 Scale.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Physical activity</measure>
    <time_frame>5 minutes</time_frame>
    <description>Physical activity level will be evaluated using International Physical Activity Questionnaire - Short Form (IPAQ-SF).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Qol</measure>
    <time_frame>10 minutes</time_frame>
    <description>Quality of life will be evaluated using SF-36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety and depression</measure>
    <time_frame>5 minutes</time_frame>
    <description>Anxiety and depression will be evaluated using Hospital Anxiety and Depression scale (HADS).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fear of movement</measure>
    <time_frame>10 minutes</time_frame>
    <description>Fear of movement will be evaluated using the Tampa Scale for Kinesiophobia</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Covid19</condition>
  <condition>Chronic Kidney Diseases</condition>
  <arm_group>
    <arm_group_label>Patients with chronic kidney disease</arm_group_label>
    <description>Having been diagnosed with chronic kidney disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy individuals</arm_group_label>
    <description>Healthy individuals without chronic disease</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients and healthy individuals between 18-65 years old, who are diagnosed with chronic&#xD;
        kidney disease, and whose local language is Turkish will be included in the study.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Having been diagnosed with chronic kidney disease&#xD;
&#xD;
          -  Being clinically stable&#xD;
&#xD;
          -  Volunteering to participate in the research&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Having a cognitive problem&#xD;
&#xD;
          -  Not being literate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Merve Firat, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Naciye Vardar-Yagli, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tolga Yildirim, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Hacettepe University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Merve Firat</last_name>
    <phone>+903123051576</phone>
    <phone_ext>178</phone_ext>
    <email>mervefirat@hacettepe.edu.tr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hacettepe University, Faculty of Physical Therapy and Rehabilitation</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Merve Firat</last_name>
      <email>mervefirat@hacettepe.edu.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>February 6, 2021</study_first_submitted>
  <study_first_submitted_qc>February 6, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>February 6, 2021</last_update_submitted>
  <last_update_submitted_qc>February 6, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hacettepe University</investigator_affiliation>
    <investigator_full_name>Merve Firat</investigator_full_name>
    <investigator_title>Research assistant</investigator_title>
  </responsible_party>
  <keyword>Fear</keyword>
  <keyword>Quality of life</keyword>
  <keyword>Anxiety</keyword>
  <keyword>Depression</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

